Table 1.

Characteristics of reported cases of AEs after receipt of COVID-19 vaccines.

Characteristics		Number of AEs reports (n = 44,451)
Gender	Male	10,637 (23.9)
	Female	32,806 (73.8)
	Unspecified	1,008 (2.2)
	December	10,640 (24.1)
VAERS reported by date (Month)	January	19,968 (45.2)
	February	8,498 (19.3)
	March	5,035 (11.4)
History of chronic disease	Cardiovascular disease (CVD)	4,599 (10.3)
	Respiratory disease	3,592 (8.1)
	Diabetes	2,564 (5.7)
	Renal disease	6,85 (1.5)
Allergies	No	30,652 (69.0)
	Yes	13,799 (31.0)
Most common AEs (mild-to-moderate)	Injection site reactions	13.480 (30.3)
	Pain	11,897 (26.7)
	Headache	8,271 (18.6)
	Chills	6,347 (14.0)
	Fatigue	5,972 (13.0)